TIG Advisors LLC’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
TIG Advisors LLC's RNAM Position: Q1 2026 in Review
TIG Advisors LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,801,683 shares — an estimated $130M sold.
TIG Advisors LLC first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $130M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- TIG Advisors LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- TIG Advisors LLC sold 1,801,683 Avidity Biosciences shares in Q1 2026, an estimated $130M.
- TIG Advisors LLC first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- TIG Advisors LLC's Avidity Biosciences position peaked at $130M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on TIG Advisors LLC's 13F filing for Q1 2026, filed 15 May 2026.